Qube Research & Technologies (QRT)
IDXX icon

Qube Research & Technologies (QRT)’s Idexx Laboratories IDXX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$103M Buy
197,476
+49,081
+33% +$26.9M 0.08% 290
2026
Q2 		$78.1M Buy
148,395
+62,745
+73% +$35.2M 0.07% 356
2026
Q1 		$48.1M Buy
85,650
+70,431
+463% +$45.2M 0.05% 439
2025
Q4 		$10.3M Buy
15,219
+6,346
+72% +$4.32M 0.01% 1325
2025
Q3 		$5.67M Buy
8,873
+2,784
+46% +$1.69M 0.01% 1677
2025
Q2 		$3.27M Sell
6,089
-257,930
-98% -$123M ﹤0.01% 1955
2025
Q1 		$111M Buy
264,019
+42,823
+19% +$18.6M 0.13% 197
2024
Q4 		$91.5M Sell
221,196
-65,026
-23% -$28.5M 0.12% 203
2024
Q3 		$145M Buy
286,222
+46,075
+19% +$22.4M 0.21% 90
2024
Q2 		$117M Sell
240,147
-58,594
-20% -$29.4M 0.18% 120
2024
Q1 		$161M Buy
298,741
+241,587
+423% +$132M 0.26% 90
2023
Q4 		$31.7M Sell
57,154
-58,315
-51% -$27.4M 0.06% 381
2023
Q3 		$50.5M Buy
115,469
+73,514
+175% +$36.7M 0.13% 198
2023
Q2 		$21.1M Buy
41,955
+21,080
+101% +$10.1M 0.08% 327
2023
Q1 		$10.4M Buy
+20,875
New +$10M 0.04% 459
2022
Q4 		– Sell
-40,048
Closed -$13M – 2713
2022
Q3 		$13M Sell
40,048
-96,825
-71% -$35.6M 0.08% 345
2022
Q2 		$48M Buy
+136,873
New +$55.8M 0.35% 52
2021
Q2 		– Sell
-21,128
Closed -$10.3M – 2506
2021
Q1 		$10.3M Buy
+21,128
New +$10.6M 0.16% 123
2019
Q4 		– Sell
-1,764
Closed -$480K – 1551
2019
Q3 		$480K Buy
+1,764
New +$491K 0.32% 90
2019
Q1 		– Sell
-2,445
Closed -$455K – 445
2018
Q4 		$455K Sell
2,445
-92
-4% -$18.9K 0.2% 136
2018
Q3 		$633K Sell
2,537
-847
-25% -$206K 0.08% 179
2018
Q2 		$738K Buy
3,384
+2,228
+193% +$459K 0.47% 38
2018
Q1 		$221K Buy
+1,156
New +$213K 0.09% 148

Other funds holding IDXX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IDXX Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Idexx Laboratories (IDXX) stake by 33% in Q3 2026, buying an estimated $26.9M and bringing the position to 197,476 shares worth $103M. The position accounts for 0.08% of the portfolio, ranked #290.

Qube Research & Technologies (QRT) first reported a position in IDXX in Q1 2018 and has held it in 23 quarters since. The position peaked at $161M in Q1 2024. 1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Qube Research & Technologies (QRT) held 197,476 shares of Idexx Laboratories worth $103M as of Q3 2026.
  • Qube Research & Technologies (QRT) bought 49,081 Idexx Laboratories shares in Q3 2026, an estimated $26.9M.
  • Idexx Laboratories made up 0.08% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #290 holding.
  • Qube Research & Technologies (QRT) first reported a position in Idexx Laboratories in Q1 2018 and has held it in 23 quarters since.
  • Qube Research & Technologies (QRT)'s Idexx Laboratories position peaked at $161M in Q1 2024.
  • 1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.